News / Spectrum

CDKL5 gene; cerebrospinal fluid; drug combo for fragile X syndrome

Here is a roundup of autism-related news and research spotted around the web for the week of 16 September.

By Jill Adams
17 September 2024 | 2 min read
comments
https://doi.org/10.53053/ZLVB8184 https://doi.org/10.53053/ZLVB8184 - opens a new tab Cite this article
  • Mice missing one or both copies of the gene CDKL5, which causes CDKL5 deficiency disorder in people, display autism-like traits as early as 2 weeks of age. Autism Research
  • Sensorimotor skills in infants predict self-regulation skills at 12 to 15 months old, and self-regulation skills in infants with autistic siblings predict autism traits at age 3. Developmental Science
  • Autism-linked genes can converge on downstream targets, and convergent effects are more prominent in mature glutamatergic neurons than in neural progenitor cells or GABA-ergic neurons, according to a preprint. bioRxiv
  • Microglia grown from an autistic person’s stem cells and missing the autism-linked gene NRXN1 actively release the proinflammatory cytokine IL-6 and fail to form functional neuronal networks. Brain, Behavior, and Immunity
Research image of microglia.
Uncurbed growth: Microglia missing the NRXN1 gene (right panel) proliferate more (pink stain) than control cells (left panel).
  • Some alterations in resting-state electroencephalograms are shared between people with autism and those with fragile X syndrome, whereas others distinguish the conditions. Journal of Neurodevelopmental Disorders
  • “The complexity of the 16p12.1 deletion and other genomic disorders calls for personalized medicine approaches that fully account for individual-level phenotypic presentation, family history, and genome-wide variant profile towards counseling, management, and potential treatment.” medRxiv
  • The composition of cerebrospinal fluid in embryonic mice is altered in the maternal immune activation mouse model of autism. Journal of Biological Chemistry
  • Combination therapy with lovastatin and minocycline decrease neuronal excitability in people with fragile X syndrome, according to a clinical trial. Spectrum covered earlier results with this drug combination in 2018. Autism Research

Sign up for the weekly Spectrum newsletter.

Stay current with the latest advancements in autism research.

Recommended reading

An illustration of a magnifying glass, checklists, and anonymous figures.
Spectrum

Spectrum 2024: Year in review

By Daisy Yuhas
23 December 2024 | 2 min read
Spectrum

Assembloids illuminate circuit-level changes linked to autism, neurodevelopment

By Sarah DeWeerdt
19 December 2024 | 0 min watch
Research image of mouse neurons.
Spectrum

DDX3X gene function; gender diversity; lithium

By Jill Adams
17 December 2024 | 2 min read

Explore more from The Transmitter

Illustration of distorted lines of different colors being pulled into a box where they are smoothed in a single multicolored line.
Top essays

The Transmitter’s favorite essays and columns of 2024

By The Transmitter
23 December 2024 | 2 min read
A curly line connects two pencils that are hovering over overlapping speech bubbles.
Top quotes

Say what? The Transmitter’s top quotes of 2024

By The Transmitter
23 December 2024 | 2 min read
Four microphones on a table with speech bubbles above them.
Top multimedia

The Transmitter’s favorite podcasts of 2024

By The Transmitter
23 December 2024 | 1 min read